Therapy Areas: AIDS & HIV
18 September 2017 - - The global Cryptococcosis market was valued at USD 4.51bn in 2016, and is expected to reach USD 6.76bn by 2025, expanding at a CAGR of 4.5% from 2017 to 2025, according...
12 September 2017 - - New York, New York-based biopharmaceutical company Bristol-Myers Squibb (NYSE: BMY) has provided results from the Phase 3 CheckMate -214 trial evaluating Opdivo (nivolumab) plus ...
29 August 2017 - - New York, New York-based biopharmaceutical company Bristol-Myers Squibb (NYSE: BMY) New York, New York-based biopharmaceutical and healthcare products specialist Pfizer Inc. (NYSE: ...
24 August 2017 - Japan-based Otsuka Pharmaceutical Co Ltd and global generic and speciality pharmaceutical company Mylan NV (NASDAQ: MYL) have entered into a licence agreement involving their respecti...
21 August 2017 - India-based Aurobindo Pharma (NSE: AUROPHARMA) has been granted tentative approval by the US Food and Drug Administration (FDA) for dolutegravir, lamivudine and tenofovir disoproxil f...
21 August 2017 - - US-based health and health care improvement group The Institute for Healthcare Improvement (IHI) has been awarded a USD 3m grant from the Bill and Melinda Gates Foundation...